Healthcare -
Biotechnology - NASDAQ - US
$ 5.06
6.75 %
$ 287 M
Market Cap
-5.95
P/E
DSGN - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities DSGN - Design Therapeutics, Inc.
52.5 M
LAST VALUE
72.61%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR